These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 18507661)

  • 1. Glucagon is absorbed from the rectum but does not hasten recovery from hypoglycaemia in patients with type 1 diabetes.
    Parker DR; Braatvedt GD; Bargiota A; Newrick PG; Brown S; Gamble G; Corrall RJ
    Br J Clin Pharmacol; 2008 Jul; 66(1):43-9. PubMed ID: 18507661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of exogenously administered glucagon versus spontaneous endogenous counter-regulation on glycaemic recovery from insulin-induced hypoglycaemia in patients with type 2 diabetes treated with a novel glucokinase activator, AZD1656, and metformin.
    Krentz AJ; Morrow L; Petersson M; Norjavaara E; Hompesch M
    Diabetes Obes Metab; 2014 Nov; 16(11):1096-101. PubMed ID: 24909093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Residual insulin secretion is not coupled to a maintained glucagon response to hypoglycaemia in long-term type 1 diabetes.
    Sjöberg S; Ahrén B; Bolinder J
    J Intern Med; 2002 Oct; 252(4):342-51. PubMed ID: 12366607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of subcutaneous, low-dose glucagon on insulin-induced mild hypoglycaemia in patients with insulin pump treated type 1 diabetes.
    Ranjan A; Schmidt S; Madsbad S; Holst JJ; Nørgaard K
    Diabetes Obes Metab; 2016 Apr; 18(4):410-8. PubMed ID: 26743775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of the amino acid alanine on glucagon secretion in non-diabetic and type 1 diabetic subjects during hyperinsulinaemic euglycaemia, hypoglycaemia and post-hypoglycaemic hyperglycaemia.
    Porcellati F; Pampanelli S; Rossetti P; Busciantella Ricci N; Marzotti S; Lucidi P; Santeusanio F; Bolli GB; Fanelli CG
    Diabetologia; 2007 Feb; 50(2):422-30. PubMed ID: 17160672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased splanchnic blood flow after hypoglycaemia in diabetic and normal man: evidence against glucagon as a mediator.
    Parker DR; Bargiota A; Braatvedt GD; Halliwell M; Corrall RJ
    Clin Sci (Lond); 1999 Feb; 96(2):179-84. PubMed ID: 9918898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Albiglutide does not impair the counter-regulatory hormone response to hypoglycaemia: a randomized, double-blind, placebo-controlled, stepped glucose clamp study in subjects with type 2 diabetes mellitus.
    Hompesch M; Jones-Leone A; Carr MC; Matthews J; Zhi H; Young M; Morrow L; Reinhardt RR
    Diabetes Obes Metab; 2015 Jan; 17(1):82-90. PubMed ID: 25263215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of sitagliptin on counter-regulatory and incretin hormones during acute hypoglycaemia in patients with type 1 diabetes: a randomized double-blind placebo-controlled crossover study.
    Schopman JE; Hoekstra JBL; Frier BM; Ackermans MT; de Sonnaville JJJ; Stades AM; Zwertbroek R; Hartmann B; Holst JJ; Knop FK; Holleman F
    Diabetes Obes Metab; 2015 Jun; 17(6):546-553. PubMed ID: 25694217
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intranasal glucagon treatment relieves hypoglycaemia in children with type 1 (insulin-dependent) diabetes mellitus.
    Stenninger E; Aman J
    Diabetologia; 1993 Oct; 36(10):931-5. PubMed ID: 8243872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Counterregulatory hormones in insulin-treated diabetic patients admitted to an accident and emergency department with hypoglycaemia.
    Hvidberg A; Christensen NJ; Hilsted J
    Diabet Med; 1998 Mar; 15(3):199-204. PubMed ID: 9545120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term administration of theophylline and glucose recovery after hypoglycaemia in patients with type 1 diabetes mellitus.
    Hvidberg A; Rosenfalck A; Christensen NJ; Hilsted J
    Diabet Med; 1998 Jul; 15(7):608-14. PubMed ID: 9686702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nasal glucagon as a viable alternative for treating insulin-induced hypoglycaemia in Japanese patients with type 1 or type 2 diabetes: A phase 3 randomized crossover study.
    Matsuhisa M; Takita Y; Nasu R; Nagai Y; Ohwaki K; Nagashima H
    Diabetes Obes Metab; 2020 Jul; 22(7):1167-1175. PubMed ID: 32115879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physiological responses during hypoglycaemia induced by regular human insulin or a novel human analogue, insulin glargine.
    Dagogo-Jack S; Askari H; Morrill B; Lehner LL; Kim B; Sha X
    Diabetes Obes Metab; 2000 Dec; 2(6):373-83. PubMed ID: 11225967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. No reactive hypoglycaemia in Type 2 diabetic patients after subcutaneous administration of GLP-1 and intravenous glucose.
    Vilsbøll T; Krarup T; Madsbad S; Holst JJ
    Diabet Med; 2001 Feb; 18(2):144-9. PubMed ID: 11251679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nasal glucagon in the treatment of hypoglycaemia in type 1 (insulin-dependent) diabetic patients.
    Rosenfalck AM; Bendtson I; Jørgensen S; Binder C
    Diabetes Res Clin Pract; 1992 Jul; 17(1):43-50. PubMed ID: 1511660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human insulin and awareness of acute hypoglycaemic symptoms in insulin-dependent diabetes.
    Patrick AW; Bodmer CW; Tieszen KL; White MC; Williams G
    Lancet; 1991 Aug; 338(8766):528-32. PubMed ID: 1678798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of dual-hormone artificial pancreas, single-hormone artificial pancreas, and conventional insulin pump therapy for glycaemic control in patients with type 1 diabetes: an open-label randomised controlled crossover trial.
    Haidar A; Legault L; Messier V; Mitre TM; Leroux C; Rabasa-Lhoret R
    Lancet Diabetes Endocrinol; 2015 Jan; 3(1):17-26. PubMed ID: 25434967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relative roles of insulin and hypoglycaemia on induction of neuroendocrine responses to, symptoms of, and deterioration of cognitive function in hypoglycaemia in male and female humans.
    Fanelli C; Pampanelli S; Epifano L; Rambotti AM; Ciofetta M; Modarelli F; Di Vincenzo A; Annibale B; Lepore M; Lalli C
    Diabetologia; 1994 Aug; 37(8):797-807. PubMed ID: 7988782
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparing hormonal and symptomatic responses to experimental hypoglycaemia in insulin- and sulphonylurea-treated Type 2 diabetes.
    Choudhary P; Lonnen K; Emery CJ; MacDonald IA; MacLeod KM; Amiel SA; Heller SR
    Diabet Med; 2009 Jul; 26(7):665-72. PubMed ID: 19573114
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Day and night glycaemic control with a bionic pancreas versus conventional insulin pump therapy in preadolescent children with type 1 diabetes: a randomised crossover trial.
    Russell SJ; Hillard MA; Balliro C; Magyar KL; Selagamsetty R; Sinha M; Grennan K; Mondesir D; Ekhlaspour L; Zheng H; Damiano ER; El-Khatib FH
    Lancet Diabetes Endocrinol; 2016 Mar; 4(3):233-243. PubMed ID: 26850709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.